In bladder and breast cancers, METTL3-mediated m6A modification of PD-L1 mRNA stabilizes the mRNA in an IGF2BP1- or IGF2BP3-dependent manner80, 81. The gene discussed is IGF2BP1; the disease is breast carcinoma.